Effectiveness of Japanese encephalitis SA 14-14-2 live attenuated vaccine among Indian children: Retrospective 1:4 matched case-control study

Journal of Infection and Public Health - Tập 11 - Trang 713-719 - 2018
Babasaheb V. Tandale1, Siraj A. Khan2, Komal P. Kushwaha3, Helina Rahman4, Milind M. Gore5
1Epidemiology, ICMR—National Institute of Virology, Pune, India
2Arbovirology, ICMR—Regional Medical Research Centre, Dibrugarh, India
3Pediatrics, Baba Raghav Das Medical College, Gorakhpur, India
4Pediatrics, Assam Medical College, Dibrugarh, India
5Encephalitis, National Institute of Virology, Gorakhpur Unit, Gorakhpur, India

Tài liệu tham khảo

Campbell, 2011, Estimated global incidence of Japanese encephalitis: a systematic review, Bull World Health Organ, 89, 766, 10.2471/BLT.10.085233 World Health Organization, 2013, Japanese encephalitis: status of surveillance and immunization in Asia and the Western Pacific, 2012, Weekly Epidemiological Record, 8834, 357 Directorate of National Vector Borne Diseases Control Programme, 2006 Tsai, 1998, New initiatives for the control of Japanese encephalitis by vaccination: minutes of a WHO/CVI meeting, Bangkok, Thailand, 13–15 October, Vaccine, 200, 1 Hennessy, 1996, Effectiveness of live-attenuated Japanese encephalitis vaccine (SA14-14-2): a case-control study, Lancet, 347, 1583, 10.1016/S0140-6736(96)91075-2 Bista, 2001, Efficacy of single-dose SA 14-14-2 vaccine against Japanese encephalitis: a case control study, Lancet, 358, 791, 10.1016/S0140-6736(01)05967-0 Ohrr, 2005, Effect of single dose of SA 14-14-2 vaccine 1 year after immunisation in Nepalese children with Japanese encephalitis: a case-control study, Lancet, 366, 1375, 10.1016/S0140-6736(05)67567-8 Tandan, 2007, Single dose of SA 14-14-2 vaccine provides long-term protection against Japanese encephalitis: a case-control study in Nepalese children 5 years after immunization, Vaccine, 25, 5041, 10.1016/j.vaccine.2007.04.052 Sohn, 2008, A 5-year follow-up of antibody response in children vaccinated with single dose of live attenuated SA14-14-2 Japanese encephalitis vaccine: immunogenicity and anamnestic responses, Vaccine, 26, 1638, 10.1016/j.vaccine.2008.01.021 Parida, 2006, Japanese encephalitis outbreak, India, 2005, Emerg Infect Dis, 12, 1427, 10.3201/eid1209.060200 World Health Organization (WHO), 2007 Solomon, 2008, A cohort 
study to assess the new WHO Japanese encephalitis surveillance standards, Bull World 
Health Organ, 86, 178, 10.2471/BLT.07.043307 Sapkal, 2007, Detection and isolation of 
Japanese encephalitis virus from blood clots collected during the acute phase of infection, Am J Trop Med Hyg, 77, 1139, 10.4269/ajtmh.2007.77.1139 Ravi, 2006, Development and evaluation of a rapid IgM capture ELISA (JEV-Chex) for the diagnosis of Japanese encephalitis, J Clin Virol, 35, 429, 10.1016/j.jcv.2005.11.004 Jacobson, 2007, Evaluation of three immunoglobulin M antibody capture enzyme-linked immunosorbent assays for diagnosis of Japanese encephalitis, Am J Trop Med Hyg, 77, 164, 10.4269/ajtmh.2007.77.164 WHO Regional Office for Southeast Asia. Fourth Bi-regional Meeting on the control of Japanese Encephalitis. Report of the meeting. Bangkok, Thailand, 7–8 June 2009 [cited 15 Aug 2013]. Available at: http://www.wpro.who.int/immunization/documents/docs/JEBiregionalMeetingJune2009final.pdf (Accessed 17 August 2017). Swami, 2008, Usefulness of RT-PCR for the diagnosis of Japanese encephalitis in clinical samples, Scand J Infect Dis, 40, 815, 10.1080/00365540802227102 Fulmali, 2011, Introduction of Japanese encephalitis virus genotype I, India, Emerg Infect Dis, 17, 319, 10.3201/eid1702.100815 Niccolai, 2007, Methodological issues in design and analysis of a matched case-control study of a vaccine’s effectiveness, J Clin Epidemiol, 60, 1127, 10.1016/j.jclinepi.2007.02.009 Orenstein, 1985, Field evaluation of vaccine efficacy, Bull World Health Organ, 63, 1055 Kumar, 2009, Effectiveness of one dose of SA 14-14-2 vaccine against Japanese encephalitis, N Engl J Med, 360, 1465, 10.1056/NEJMc0808664 UNICEF United Nations Children’s Fund, 2008 Kumari, 2012, A review of Japanese encephalitis in Uttar Pradesh, India, WHO South East Asia J. Public Health, 1, 374, 10.4103/2224-3151.207040 Saxena, 2009, Trend of Japanese encephalitis in North India: evidence from thirty-eight acute encephalitis cases and appraisal of niceties, J Infect Dev Countries, 3, 517, 10.3855/jidc.470 Borthakur, 2013, Data from the World Health Organization (WHO) National Network Laboratory for Japanese encephalitis, J Glob Infect Dis, 5, 76, 10.4103/0974-777X.112294 Indian Academy of Pediatrics, 2013, Indian Academy of Pediatrics (IAP) recommended immunization schedule for children aged 0 through 18 years – India, 2013 and updates on immunization, Indian Pediatrics, 50, 1095, 10.1007/s13312-013-0292-9 Verma, 2012, Japanese encephalitis vaccine: need of the hour in endemic states of India, Hum Vaccine Immunother, 8, 491, 10.4161/hv.18925 Singh, 2014, Economic evaluation of Japanese encephalitis vaccination programme in Uttar Pradesh, India: a cost-benefit study, J Vector Borne Dis, 51, 47 Upreti, 2013, Estimation of the impact of a Japanese encephalitis immunization program with live, attenuated SA 14-14-2 vaccine in Nepal, Am J Trop Med Hyg, 88, 464, 10.4269/ajtmh.12-0196 Murhekar, 2014, Low coverage and acceptable effectiveness of single dose of Japanese encephalitis vaccine, Gorakhpur division, Uttar Pradesh, India, 2013, J Infect, 69, 517, 10.1016/j.jinf.2014.06.017